Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2568 | 2134 | 40.0 | 86% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 40 | 31853 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HIV 1 GP41 | Author keyword | 6 | 29% | 1% | 16 |
| 2 | GP120 CD4 INTERACTION | Author keyword | 5 | 60% | 0% | 6 |
| 3 | CD4 RECEPTOR | Author keyword | 4 | 28% | 1% | 11 |
| 4 | SECT PHARMACOKINET DRUG DELIVERY | Address | 3 | 57% | 0% | 4 |
| 5 | GP120 PEPTIDES | Author keyword | 3 | 100% | 0% | 3 |
| 6 | RECOMBINANT CD4 | Author keyword | 3 | 100% | 0% | 3 |
| 7 | SUC HSA | Author keyword | 3 | 100% | 0% | 3 |
| 8 | TRYPTASE TL2 | Author keyword | 3 | 100% | 0% | 3 |
| 9 | CD4 GP120 INTERACTION | Author keyword | 3 | 60% | 0% | 3 |
| 10 | GP120 41 | Author keyword | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HIV 1 GP41 | 6 | 29% | 1% | 16 | Search HIV+1+GP41 | Search HIV+1+GP41 |
| 2 | GP120 CD4 INTERACTION | 5 | 60% | 0% | 6 | Search GP120+CD4+INTERACTION | Search GP120+CD4+INTERACTION |
| 3 | CD4 RECEPTOR | 4 | 28% | 1% | 11 | Search CD4+RECEPTOR | Search CD4+RECEPTOR |
| 4 | GP120 PEPTIDES | 3 | 100% | 0% | 3 | Search GP120+PEPTIDES | Search GP120+PEPTIDES |
| 5 | RECOMBINANT CD4 | 3 | 100% | 0% | 3 | Search RECOMBINANT+CD4 | Search RECOMBINANT+CD4 |
| 6 | SUC HSA | 3 | 100% | 0% | 3 | Search SUC+HSA | Search SUC+HSA |
| 7 | TRYPTASE TL2 | 3 | 100% | 0% | 3 | Search TRYPTASE+TL2 | Search TRYPTASE+TL2 |
| 8 | CD4 GP120 INTERACTION | 3 | 60% | 0% | 3 | Search CD4+GP120+INTERACTION | Search CD4+GP120+INTERACTION |
| 9 | GP120 41 | 3 | 60% | 0% | 3 | Search GP120+41 | Search GP120+41 |
| 10 | CD4 CELL DEPLETION | 2 | 67% | 0% | 2 | Search CD4+CELL+DEPLETION | Search CD4+CELL+DEPLETION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | T4 MOLECULE | 51 | 51% | 3% | 72 |
| 2 | SOLUBLE CD4 | 48 | 27% | 7% | 156 |
| 3 | HTLV III LAV ENVELOPE | 44 | 42% | 4% | 82 |
| 4 | RECOMBINANT SOLUBLE CD4 | 33 | 41% | 3% | 64 |
| 5 | CDR3 LIKE REGION | 32 | 88% | 1% | 15 |
| 6 | AIDS RETROVIRUS | 28 | 48% | 2% | 43 |
| 7 | SYNCYTIUM FORMATION | 27 | 20% | 6% | 126 |
| 8 | SYNCYTIA FORMATION | 21 | 75% | 1% | 15 |
| 9 | RAT CD4 | 19 | 80% | 1% | 12 |
| 10 | HTLV III LAV | 18 | 17% | 4% | 95 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION | 1993 | 883 | 1175 | 21% |
| THE ROLE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS IN VIRUS-INFECTION | 1995 | 175 | 142 | 57% |
| Polyanions - a lost chance in the fight against HIV and other virus diseases? | 2000 | 60 | 59 | 31% |
| ANTIVIRAL PORTRAIT SERIES .4. POLYSULFATES AS INHIBITORS OF HIV AND OTHER ENVELOPED VIRUSES | 1994 | 81 | 87 | 51% |
| Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions | 1996 | 86 | 369 | 28% |
| Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects? | 2004 | 48 | 69 | 25% |
| THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) CD4 RECEPTOR AND ITS CENTRAL ROLE IN PROMOTION OF HIV-1 INFECTION | 1995 | 104 | 495 | 34% |
| HIV and the 7-transmembrane domain receptors | 1996 | 46 | 94 | 44% |
| The role of CD4 in HIV envelope-mediated pathogenesis | 1996 | 35 | 115 | 47% |
| The receptor for HIV: Dissection of CD4 and studies on putative accessory factors | 1996 | 14 | 140 | 84% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SECT PHARMACOKINET DRUG DELIVERY | 3 | 57% | 0.2% | 4 |
| 2 | IMMUNOL INFECT RETROVIRALES | 2 | 43% | 0.1% | 3 |
| 3 | HIV PROT INTERACT | 1 | 50% | 0.1% | 2 |
| 4 | HIV VIROL AUSTRALIA | 1 | 100% | 0.1% | 2 |
| 5 | INFECT RETROVIRALES SIGNALISAT CELLULAIRE | 1 | 17% | 0.3% | 7 |
| 6 | BIOCHEM ORAL BIOL | 1 | 50% | 0.0% | 1 |
| 7 | BIOL GENET DEFICITS IMMUNITAI | 1 | 50% | 0.0% | 1 |
| 8 | CELL BIOL BLDG 36 ROOM 3A17 | 1 | 50% | 0.0% | 1 |
| 9 | CLIN SCI IMPERIAL CANC FUND | 1 | 50% | 0.0% | 1 |
| 10 | CNRSERS 155 | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000203034 | ANTI R7V ANTIBODIES//C ADE//T CELL INFECTION |
| 2 | 0.0000179440 | HGP 30//VACCINE DEV BRANCH//HIV 1 IMMUNOGEN |
| 3 | 0.0000162400 | IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER |
| 4 | 0.0000123822 | SERV REG MALAD INFECT//EQUIPE INTERFERON CYTOKINES//PHARMA NEW TECHNOL |
| 5 | 0.0000121536 | UF SIDA//KODECYTE//ESA CNRS 6033 |
| 6 | 0.0000121450 | ELECTRON ION INTERACTION POTENTIAL//INFORMATIONAL SPECTRUM METHOD//DECEPTIVE IMPRINTING |
| 7 | 0.0000119873 | MED HOWARD HUGHES MED PATHOL//CD8 BETA//CD8 IMMUNODEFICIENCY |
| 8 | 0.0000113490 | EMI U 9922//UNITE PHYSIOPATHOL INFECT LENTIVIRALES//DIPARTIMENTO IGIENE MED PREVENT SANITA PUBBL |
| 9 | 0.0000112879 | AIDS RESEARCH//IMMUNE COMPLEX DISSOCIATION//ANNALES DE L INSTITUT PASTEUR-VIROLOGY |
| 10 | 0.0000111673 | HIV 2//HIV 2 INFECTION//GUINEA BISSAU |